reference/17332680

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/17332680

Outgoing Links

Predicate	Object
contentType	Clinical Trial\|Journal Article\|Multicenter Study\|Research Support, N.I.H., Extramural
endingPage	14
issn	0098-7484
issueIdentifier	7
pageRange	806-14
publicationName	JAMA
startingPage	806
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_199db1bef4b0308c0639203aa0befa4f http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_448c3d7a8b95445db230c0de0b6d375a
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_128cd3e5c76bee46e15fef889d13aa92 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_7ebe3e62266198642ac8cbf1d33d5722 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_f07d441d92baab8ca75ce9e4fe18eb74 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_76f6732138744faa0c35a4bf1f1b7735 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_c8c5ec6ee9b730a5ab820e584b34c1a9 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_1ac80d28e2728eb9c147e187f729f696 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_07ad5655ac17bb5608a6979c4c276d58 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_4e03c33cb9eb7b19fb0d477c02e7c180 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_3262aad17c11eed3e893ceae14df229a http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_63432fe7e869afd906042af8e07f26e7 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_2e230f5a211013d9f7f3116706f3ab84 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_ee0e30f4456878e64954b1f6882f5a8c http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_a7e01d23193f2efd7514922e973283d6 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_1b597d6efb4b44be9c0bffd105835f12 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_a249f60eb85f15ea4b747c90db804c3a
bibliographicCitation	Swindells S, DiRienzo AG, Wilkin T, Fletcher CV, Margolis DM, Thal GD, Godfrey C, Bastow B, Ray MG, Wang H, Coombs RW, McKinnon J, Mellors JW; AIDS Clinical Trials Group 5201 Study Team. Regimen simplification to atazanavir-ritonavir alone as maintenance antiretroviral therapy after sustained virologic suppression. JAMA. 2006 Aug 16;296(7):806–14. doi: 10.1001/jama.296.7.806. PMID: 16905786.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1607496ea4c4584cb64b7cafb7de52a9 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ec9ccc604e42bd18015be215a02c823f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_75f6a601ebdae8a680c669da37264ced http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1a3a816976707a6ebd6a322e27bc89cf http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1eeccdf9ecfc4d00d4ac757fc494228d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cc6057f7bfbbbd30c6c0ad1300e517f5 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_17030427aabdc1f656cdfca6a875df75 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8a3ce5124d9f7557f46bf586b33ee896 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_02fb0ba56a5bcca482bb3a47f5109b88 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_30b61db92c2e5704b6ec5a028baf3bf4 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_eb0efbdfaf5ff769491550a0225e62e3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2cc3c1466cf9eb75562fa7c15e9b2c05 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_380de1324e0fb4759ba60d5b72f95478
date	2006-08-16^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://doi.org/10.1001/jama.296.7.806 https://pubmed.ncbi.nlm.nih.gov/16905786
isPartOf	https://portal.issn.org/resource/ISSN/0098-7484 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/5346
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Regimen Simplification to Atazanavir-Ritonavir Alone as Maintenance Antiretroviral Therapy After Sustained Virologic Suppression
discusses	http://id.nlm.nih.gov/mesh/M0445555 http://id.nlm.nih.gov/mesh/M0015279 http://id.nlm.nih.gov/mesh/M0019167 http://id.nlm.nih.gov/mesh/M0026300 http://id.nlm.nih.gov/mesh/M0028918 http://id.nlm.nih.gov/mesh/M0018233 http://id.nlm.nih.gov/mesh/M0028839
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D019380Q000008 http://id.nlm.nih.gov/mesh/D011725Q000008 http://id.nlm.nih.gov/mesh/D015658Q000188 http://id.nlm.nih.gov/mesh/D017320Q000008 http://id.nlm.nih.gov/mesh/D009842Q000008 http://id.nlm.nih.gov/mesh/D019438Q000008
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D010349 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D015658Q000097 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D012333Q000097 http://id.nlm.nih.gov/mesh/D017320Q000493 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D019562 http://id.nlm.nih.gov/mesh/D009842Q000493 http://id.nlm.nih.gov/mesh/D015497Q000235 http://id.nlm.nih.gov/mesh/D019380Q000493 http://id.nlm.nih.gov/mesh/D010865 http://id.nlm.nih.gov/mesh/D018791 http://id.nlm.nih.gov/mesh/D023241 http://id.nlm.nih.gov/mesh/D011725Q000493 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D000069446
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID392622 http://rdf.ncbi.nlm.nih.gov/pubchem/protein/EC_2.7.7.49 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID148192 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_68000b5f90a1d5b5b1a93dbb8aa92d3e http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_89d708279e197fec68596fc46bc48c90 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6780 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9765 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_0943bfb20a0e8ebccd479b74c7b652df http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6530

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127474087 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128681033

Showing number of triples: 1 to 89 of 89.